Results 161 to 170 of about 642,659 (199)

Methodological Challenges of Emulating a Target Trial to Assess Effectiveness of Timing of PCSK9 Inhibitor Treatment Initiation Post Myocardial Infarction. [PDF]

Pharmacoepidemiol Drug Saf
Cars T, Gustafsson S, Chan Q, Dhalwani N, Kent ST, Briggs A, Gale CP, Gitt A, Jukema JW, Steg PG, Sundström J, James S, Hagström E, Brookhart MA.   +13 more
europepmc   +1 more source

Laroprovstat, the First Oral Small-Molecule PCSK9 Inhibitor for the Treatment of Hypercholesterolemia: Results From a Randomized, Single-Blind, Placebo-Controlled Phase 1 Trial in Treatment-Naïve Patients. [PDF]

Circulation
Vega RB, O'Mahony G, Barbour AM, Yu H, Knöchel J, Brengdahl J, Hochdörfer T, Bergenholm L, Töppner Carlsson E, Ahnmark A, Underwood CR, Rudvik A, Carter D, Laru J, Gutgsell A, Twaddle L, Garkaviy P, Bogstedt A, Hurt-Camejo E, Miliotis T, Ryaboshapkina M, Hober A, Hubbard B, Serrano-Wu M, Kaushik V, Geschwindner S, McCarthy MC, Lindén D, Rosenmeier JB.   +28 more
europepmc   +1 more source

Impact of CYP2C19 Genotype Variants on PCSK9 Inhibitor Efficacy in Lipid-Lowering Among Patients With Symptomatic Intracranial Atherosclerotic Stenosis. [PDF]

Lipids
Zhao C, Wang N, Shi D, Zhou H, Chen D, Chen G.   +5 more
europepmc   +1 more source

Acute Myocardial Infarction from Stent Thrombosis Following a Loss to Follow-up Triggered by Financial Barriers to PCSK9 Inhibitor Therapy. [PDF]

Intern Med
Nagao T, Arai R, Nishiwaki T, Tanaka Y, Hori K, Ebuchi Y, Okumura Y.   +6 more
europepmc   +1 more source

PCSK9 inhibitor failure in a statin-intolerant FH patient with a novel LDLR variant: a case report. [PDF]

Front Cardiovasc Med
Li Y, Jiang H, Xiong Y, Yan S, Chen X.
europepmc   +1 more source

PCSK9 Inhibitor and Potential Decreased Risk of Neoplasms, Especially in Females: A Meta-Analysis. [PDF]

Pharmaceuticals (Basel)
Wei T, Li Z, Lin C, Yang Y, Tie C, Cai X, Lv F, Yang W, Ji L.   +8 more
europepmc   +1 more source

Impact of PCSK9 inhibitor on T lymphocyte subsets and cytokines in patients with acute ischemic stroke: an exploratory analysis of a randomized clinical trial. [PDF]

Front Neurol
Liu J, Han C, Ji X, Cao H, Chen S, Tan C, Hao X, Joyama Y, Zou W, Li Y, Liu J.   +10 more
europepmc   +1 more source

Dual-targeted albumin nanoparticles for the Co-delivery of low-dose paclitaxel and PCSK9 inhibitor in melanoma treatment. [PDF]

Mater Today Bio
Chen L, Hu M, Yan HM, Ding XQ, Yang QX, Wang L, Pan H.   +6 more
europepmc   +1 more source

A PCSK9 gátló kezelés hatása a szekunder kardiovaszkuláris prevencióban

Bevezetés: A már egyszer kardiovaszkuláris eseményt elszenvedett betegek körében prognosztikai jelentőségű a hatékony szekunder prevenció részeként az egyre szigorúbb koleszterin célértékek elérése. Ugyanakkor, a betegek egy része nem tolerálja a sztatin
Berencsi, Fruzsina
core  

Combined Use of Statin and PCSK9 Inhibitor in a Pregnant Woman with Possible Familial Hypercholesterolemia and Coronary Artery Stenosis. [PDF]

J Atheroscler Thromb
Shimizu Y, Yokouchi-Konishi T, Aoki-Kamiya C, Temukai M, Hizuka K, Sawada M, Kakigano A, Iwanaga N, Kanagawa T, Murai K, Makino H, Yoshimatsu J.   +11 more
europepmc   +1 more source